EUVIMEDDescoperă EUVIMED
VergleichsstudieOpen access · CC BY 4.0

A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards

Florian Klinglmüller iD, Tobias Fellinger iD, Franz König iD, Tim Friede iD, Andrew C Hooker iD, Harald Heinzl iD, Martina Mittlböck iD, Jonas Brugger iD, Maximilian Bardo iD, Cynthia Huber iD, Norbert Benda, Martin Posch iD and 1 more

Statistics in Medicine · 2025-02-28 · 44 (5)

DOI: 10.1002/sim.70019 ↗

At a glance

Vergleichsstudie in Statistics in Medicine, published online on 2025-02-20. Written by Florian Klinglmüller and 12 co-authors. Institution: Austrian Agency for Health and Food Safety, Vienna, Austria. Major MEDLINE topics: Randomized Controlled Trials as Topic. Cited 11 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Medicines Agency.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

While well‐established methods for time‐to‐event data are available when the proportional hazards assumption holds, there is no consensus on the best inferential approach under non‐proportional hazards (NPH). However, a wide range of parametric and non‐parametric methods for testing and estimation in this scenario have been proposed. To provide recommendations on the statistical analysis of clinical trials where non‐proportional hazards are expected, we conducted a simulation study under different scenarios of non‐proportional hazards, including delayed onset of treatment effect, crossing hazard curves, subgroups with different treatment effects, and changing hazards after disease progression. We assessed type I error rate control, power, and confidence interval coverage, where applicable, for a wide range of methods, including weighted log‐rank tests, the MaxCombo test, summary measures such as the restricted mean survival time (RMST), average hazard ratios, and milestone survival probabilities, as well as accelerated failure time regression models. We found a trade‐off between interpretability and power when choosing an analysis strategy under NPH scenarios. While analysis methods based on weighted logrank tests typically were favorable in terms of power, they do not provide an easily interpretable treatment effect estimate. Also, depending on the weight function, they test a narrow null hypothesis of equal hazard functions, and rejection of this null hypothesis may not allow for a direct conclusion of treatment benefit in terms of the survival function. In contrast, non‐parametric procedures based on well‐interpretable measures like the RMST difference had lower power in most scenarios. Model‐based methods based on specific survival distributions had larger power; however, often gave biased estimates and lower than nominal confidence interval coverage. The application of the studied methods is illustrated in a case study with reconstructed data from a phase III oncologic trial.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicHumansProportional Hazards ModelsComputer SimulationData Interpretation, StatisticalModels, StatisticalSurvival AnalysisConfidence Intervals

Author keywords

clinical trialnon‐proportional hazardssurvival analysis

Authors and institutions

  • Austrian Agency for Health and Food Safety, Vienna, Austria.
  • Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Dept. of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.

ORCID profiles: Florian Klinglmüller, Tobias Fellinger, Franz König, Tim Friede, Andrew C Hooker, Harald Heinzl, Martina Mittlböck, Jonas Brugger, Maximilian Bardo, Cynthia Huber, Martin Posch, Robin Ristl

Funding

  • European Medicines Agency

Cite

APA

Klinglmüller, F., Fellinger, T., König, F., Friede, T., Hooker, A. C., Heinzl, H., Mittlböck, M., Brugger, J., Bardo, M., Huber, C., Benda, N., Posch, M., & Ristl, R. (2025). A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards. Statistics in Medicine, 44(5). https://doi.org/10.1002/sim.70019

Vancouver

Klinglmüller F, Fellinger T, König F, Friede T, Hooker AC, Heinzl H, et al. A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards. Statistics in Medicine. 2025;44(5). doi:10.1002/sim.70019

BibTeX
@article{Klinglmller2025,
  author = {Klinglmüller, Florian and Fellinger, Tobias and König, Franz and Friede, Tim and Hooker, Andrew C and Heinzl, Harald and Mittlböck, Martina and Brugger, Jonas and Bardo, Maximilian and Huber, Cynthia and Benda, Norbert and Posch, Martin and Ristl, Robin},
  title = {A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards},
  journal = {Statistics in Medicine},
  year = {2025},
  volume = {44},
  number = {5},
  doi = {10.1002/sim.70019}
}
Start for free →